ELAINE WELCH: Open Payments
NPI 1003516089 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 28 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $794 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 15 | $539 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| CVRx, Inc. | 2 | $63 |
| PFIZER INC. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: CARDIOMEMS, VERQUVO, Barostim Neo System, VYNDAQEL, FUROSCIX, CAMZYOS, WAINUA, LifeVest.
Industry payments across MO — which companies pay providers there.
